Arvinas adds oncology, neurology experts to SAB

Arvinas has announced that six new thought leaders will join the company’s scientific advisory board. The new members are Tomasz M. Beer, M.D., F.A.C.P., Adam L. Boxer, M.D., Ph.D., Sara Courtneidge, Ph.D., Lennart Mucke, M.D., Benjamin G. Neel, M.D., Ph.D., and Lillian L. Siu, M.D.

“The past year was an inflection point full of significant milestones as we advanced two PROTAC® protein degraders into the clinic,” said John Houston, Ph.D., President and Chief Executive Officer of Arvinas. “Our scientific advisory board has been critical to the advancement of the Arvinas portfolio.” more